NSECopy of Newspaper Publication4d ago · 15 Aug 2026, 06:37 pm

Copy of Newspaper Publication

Glenmark Pharmaceuticals Limited · GLENMARK

✦ AI Summary

Glenmark Pharmaceuticals has informed the Exchange about a copy of a newspaper publication regarding the 48th Annual General Meeting to be held on September 11, 2026, through Video Conferencing or Other Audio-Visual Means.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

Attachments (1)

📄

GLENMARK_15082026183615_NSE_BSE_Newspaper_Publication_signed.pdf

pdf

Download →
View document text
August 15, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, “Exchange Plaza”, Corporate Relationship Department, 5th Floor, Plot No. C/1, G Block, 2nd Floor, New Trading Ring, Bandra- Kurla Complex, Bandra (East), P.J. Towers, Dalal Street, Mumbai – 400 051 Mumbai – 400 001 Scrip Name: GLENMARK Scrip Code: 532296 ISIN: INE935A01035 ISIN: INE935A01035 Our Reference No. 50/26-27 Our Reference No. 50/26-27 Dear Sir/ Madam, Sub: Newspaper Advertisement regarding the 48th Annual General Meeting (“the AGM”) to be held on Friday, September 11, 2026 at 2.00 p.m. through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”) Pursuant to the provisions of the Companies Act, 2013, the applicable Rules made thereunder, the General Circular No. 03/2025 dated September 22, 2025 (hereinafter referred to as “Circular”) issued by the Ministry of Corporate Affairs (“MCA”) and the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has made a public notice informing about 48th Annual General Meeting of the Company through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”) scheduled to be held on Friday, September 11, 2026 at 2.00 p.m. We hereby submit the copies of the public notice published in English daily “Financial Express” and Marathi daily “Loksatta” – All Editions, on Saturday, August 15, 2026, for your information and the same is also uploaded on the website of the Company at https://glenmarkpharma.com/ You are requested to take the above on record. Thanking you. Yours faithfully, For Glenmark Pharmaceuticals Limited Rashmi Khandelwal Company Secretary & Compliance Officer ACS – 28839 Encl: As above Glenmark Pharmaceuticals Limited Glenmark House, B D Sawant Marg, Andheri (E), Mumbai 400 099 T: 91 22 4018 9999 F: 91 22 4018 9988 CIN No: L24299MH1977PLC019982 W: www.glenmarkpharma.com Registered office: B/2, Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai 400 026 E: complianceofficer@glenmarkpharma.com